Dario Scimeca Precision Biosciences Inc (DTIL) insider trading activity

DTIL Quotes by TradingView

Dario Scimeca is General Counsel and Secretary of PRECISION BIOSCIENCES INC. Currently has a direct ownership of 7,969 shares of DTIL, which is worth approximately $35,860. The most recent transaction as insider was on Nov 04, 2024, when has been sold 588 shares (Common Stock) at a price of $8.19 per share, resulting in proceeds of $4,815. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.97K
18.57% 3M change
92.95% 12M change
Total Value Held $35,860

Dario Scimeca Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 04 2024
SELL
Open market or private sale
$4,815 $8.19 p/Share
588 Reduced 6.87%
7,969 Common Stock
Nov 02 2024
BUY
Exercise of conversion of derivative security
-
1,836 Added 17.67%
8,557 Common Stock
Jun 10 2024
SELL
Open market or private sale
$1,096 $11.79 p/Share
93 Reduced 1.36%
6,721 Common Stock
Jun 07 2024
BUY
Exercise of conversion of derivative security
-
301 Added 4.23%
6,814 Common Stock
May 08 2024
BUY
Grant, award, or other acquisition
$9,996 $12.0 p/Share
833 Added 11.34%
6,513 Common Stock
May 02 2024
SELL
Open market or private sale
$2,807 $10.32 p/Share
272 Reduced 4.57%
5,680 Common Stock
May 01 2024
BUY
Exercise of conversion of derivative security
-
918 Added 13.36%
5,952 Common Stock
Jan 22 2024
SELL
Open market or private sale
$7,663 $0.36 p/Share
21,287 Reduced 12.35%
151,028 Common Stock
Jan 20 2024
BUY
Exercise of conversion of derivative security
-
59,345 Added 25.62%
172,315 Common Stock
Nov 03 2023
SELL
Open market or private sale
$6,409 $0.4 p/Share
16,023 Reduced 12.42%
112,970 Common Stock
Nov 02 2023
BUY
Exercise of conversion of derivative security
-
55,077 Added 29.92%
128,993 Common Stock
Aug 31 2023
BUY
Grant, award, or other acquisition
$2,122 $0.39 p/Share
5,443 Added 6.86%
73,916 Common Stock
Jun 08 2023
SELL
Open market or private sale
$10,020 $0.75 p/Share
13,361 Reduced 16.33%
68,473 Common Stock
Jun 07 2023
BUY
Exercise of conversion of derivative security
-
31,771 Added 27.97%
81,834 Common Stock
Mar 06 2023
SELL
Open market or private sale
$13,024 $1.07 p/Share
12,172 Reduced 19.56%
50,063 Common Stock
Mar 03 2023
BUY
Exercise of conversion of derivative security
-
27,558 Added 30.69%
62,235 Common Stock
Feb 28 2023
BUY
Grant, award, or other acquisition
$2,054 $0.95 p/Share
2,163 Added 5.87%
34,677 Common Stock
Jun 08 2022
SELL
Open market or private sale
$20,256 $2.06 p/Share
9,833 Reduced 23.22%
32,514 Common Stock
Jun 07 2022
BUY
Exercise of conversion of derivative security
-
31,774 Added 42.87%
42,347 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
$7,397 $3.61 p/Share
2,049 Added 16.23%
10,573 Common Stock
Aug 31 2021
BUY
Grant, award, or other acquisition
$5,853 $10.68 p/Share
548 Added 6.04%
8,524 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
$12,668 $4.61 p/Share
2,748 Added 25.62%
7,976 Common Stock
Aug 31 2020
BUY
Grant, award, or other acquisition
$15,117 $4.79 p/Share
3,156 Added 37.64%
5,228 Common Stock
Feb 28 2020
BUY
Grant, award, or other acquisition
$11,624 $5.61 p/Share
2,072 Added 50.0%
2,072 Common Stock
DS

Dario Scimeca

General Counsel and Secretary
Durham, NC

Track Institutional and Insider Activities on DTIL

Follow PRECISION BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DTIL shares.

Notify only if

Insider Trading

Get notified when an Precision Biosciences Inc insider buys or sells DTIL shares.

Notify only if

News

Receive news related to PRECISION BIOSCIENCES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DTIL